EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease

Kyoungrae Kim iD, Trace Thome, Caroline Pass iD, Lauren Stone iD, Nicholas Vugman iD, Victoria Palzkill iD, Qingping Yang iD, Kerri A O'Malley, Erik M Anderson iD, Brian Fazzone iD, Feng Yue iD, Scott A Berceli iD und 2 weitere

Circulation Research · 2025

DOI: 10.1161/circresaha.124.325642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Kyoungrae Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physiology and Kinesiology (K.K., T.T., C.P., L.S., N.V., V.P., Q.Y., T.E.R.). Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Renal Insufficiency, Chronic, Muscle, Skeletal, Metabolomics. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic kidney disease (CKD) has emerged as a significant risk factor that accelerates atherosclerosis, decreases muscle function, and increases the risk of amputation or death in patients with peripheral artery disease (PAD). However, the modulators underlying this exacerbated pathobiology are ill-defined. Recent work has demonstrated that uremic toxins are associated with limb amputation in PAD and have pathological effects in both the limb muscle and vasculature. Herein, we use multiomics to identify novel modulators of disease pathobiology in patients with PAD and CKD. METHODS: A cross-sectional study enrolled 4 groups of participants: controls without PAD or CKD (n=28), patients with PAD only (n=46), patients with CKD only (n=31), and patients with both PAD and CKD (n=18). Both targeted (uremic toxins) and nontargeted metabolomics in plasma were performed using mass spectrometry. Calf muscle biopsies were used to measure histopathology, perform bulk and single-nucleus RNA sequencing, and assess mitochondrial function. Differential gene and metabolite analyses, as well as pathway and gene set enrichment analyses, were performed. RESULTS: Patients with both PAD and CKD exhibited significantly lower calf muscle strength and smaller muscle fiber areas compared with controls and those with only PAD. Compared with controls, mitochondrial function was impaired in patients with CKD, with or without PAD, but not in PAD patients without CKD. Plasma metabolomics revealed substantial alterations in the metabolome of patients with CKD, with significant correlations observed between uremic toxins (eg, kynurenine and indoxyl sulfate) and both muscle strength and mitochondrial function. RNA sequencing analyses identified downregulation of mitochondrial genes and pathways associated with protein translation in patients with both PAD and CKD. Single-nucleus RNA sequencing further highlighted a mitochondrial deficiency in muscle fibers along with unique remodeling of fibro-adipogenic progenitor cells in patients with both PAD and CKD, with an increase in adipogenic cell populations. CONCLUSIONS: CKD significantly exacerbates ischemic muscle pathology in PAD, as evidenced by diminished muscle strength, reduced mitochondrial function, and altered transcriptome profiles. The correlation between uremic toxins and muscle dysfunction suggests that targeting these metabolites may offer therapeutic potential for improving muscle health in PAD patients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseRenal Insufficiency, ChronicMuscle, SkeletalMetabolomicsHumansMaleFemaleCross-Sectional StudiesMiddle AgedAgedUremic ToxinsMetabolomeTranscriptomeMuscle Strength

Stichwörter der Autor:innen

mitochondriamusclesperipheral arterial diseaserenal insufficiency, chronicuremia

Substanzen

Uremic Toxins

Autor:innen und Institutionen

  • Department of Applied Physiology and Kinesiology (K.K., T.T., C.P., L.S., N.V., V.P., Q.Y., T.E.R.).
  • Department of Surgery (K.A.O., E.M.A., B.F., S.A.B., S.T.S.).
  • Department of Animal Sciences (F.Y.).
  • Myology Institute (F.Y., T.E.R.).
  • Center for Exercise Science (T.E.R.).
  • University of Florida, Gainesville (T.E.R.).

ORCID-Profile: Kyoungrae Kim, Caroline Pass, Lauren Stone, Nicholas Vugman, Victoria Palzkill, Qingping Yang, Erik M Anderson, Brian Fazzone, Feng Yue, Scott A Berceli, Salvatore T Scali, Terence E Ryan

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Kim, K., Thome, T., Pass, C., Stone, L., Vugman, N., Palzkill, V., Yang, Q., O'Malley, K. A., Anderson, E. M., Fazzone, B., Yue, F., Berceli, S. A., Scali, S. T., & Ryan, T. E. (2025). Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease. Circulation Research. https://doi.org/10.1161/circresaha.124.325642

Vancouver

Kim K, Thome T, Pass C, Stone L, Vugman N, Palzkill V, et al. Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease. Circulation Research. 2025. doi:10.1161/circresaha.124.325642

BibTeX
@article{Kim2025,
  author = {Kim, Kyoungrae and Thome, Trace and Pass, Caroline and Stone, Lauren and Vugman, Nicholas and Palzkill, Victoria and Yang, Qingping and O'Malley, Kerri A and Anderson, Erik M and Fazzone, Brian and Yue, Feng and Berceli, Scott A and Scali, Salvatore T and Ryan, Terence E},
  title = {Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease},
  journal = {Circulation Research},
  year = {2025},
  doi = {10.1161/circresaha.124.325642}
}
Kostenlos starten →